AZAINDOLES

摘要

The invention is directed to physiologically active compounds of general formula (I): and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and the ir prodrugs, as well as to novel compounds within the scope of formula (I). Suc h compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.